Road clear for UPL to buy Arysta LifeScience

UPL has received all regulatory approvals for the acquisition of Arysta LifeScience Inc and its subsidiaries from Platform Speciality Products Corporation, an entity listed in the US. The transaction is expected to be completed on January 31, UPL said in a notice to the exchanges. In July 2018, UPL (formerly United Phosphates) teamed up with Abu Dhabi Investment Authority and TPG to snap up Florida-based Arysta LifeScience for $4.2 billion in an all-cash deal.